DNA methylation regulates mouse cardiac myofibril gene expression during heart development

Area of Science:

• Developmental Biology
• Epigenetics
• Molecular Cardiology

Background:

• Epigenetic modifications regulate gene expression during development.
• Fetal troponin I (ssTnI) gene expression is developmentally regulated, decreasing after birth.
• Mechanisms of ssTnI developmental regulation remain unclear.

Purpose of the Study:

• To investigate the epigenetic role of DNA methylation in regulating ssTnI gene expression during heart development.

Main Methods:

• DNA methylation analysis using methylation-specific PCR (MSP) and bisulfite sequencing PCR (BSP).
• Quantification of ssTnI mRNA and protein expression via real-time RT-PCR and Western blot.
• Inhibition of DNA methylation using 5-Azacytidine in cultured myocardial cells.

Main Results:

• DNA methylation levels in the ssTnI gene promoter's CpG dinucleotides region increased with development.
• Increased DNA methylation correlated with decreased ssTnI gene expression in mouse hearts.
• CpG island methylation in the ssTnI gene remained unchanged during development.
• 5-Azacytidine treatment partially prevented the decline of ssTnI expression in cultured cells.

Conclusions:

• DNA methylation acts as an epigenetic regulator of fetal troponin I gene expression in the developing heart.
• These findings highlight the role of DNA methylation in controlling developmental gene silencing.